Mammoth Biosciences
Business Services · California, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
1000 Marina Blvd Ste 600, Brisbane, Cali...Phone Number
(650) 294-8583Website
mammoth.bioRevenue
$23.2 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
2
2
3
1
1
1
About Mammoth Biosciences
Mammoth Biosciences is a biotechnology company leveraging the diversity of life to build the next generation of CRISPR products to cure and detect disease. The company is based in Brisbane, California.Explore more
Mammoth Biosciences Org Chart
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Mammoth Biosciences your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Website visits: Recent activity has been detected on your website
Earning: See what the market has to say on Mammoth Biosciences recently announced quarterly report
Check if Mammoth Biosciences has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when Mammoth Biosciences launches new products
Check out if Mammoth Biosciences is spiking on competitors!
Mammoth Biosciences, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at Mammoth Biosciences
Click to see if Mammoth Biosciences had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once Mammoth Biosciences has new funding data
Recommended Actions
Reach out to Masked Content who joined Mammoth Biosciences as Masked Content
Find more new buyers
Compare Similar Companies to Mammoth Biosciences
Compare insights from companies similar to Mammoth Biosciences, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Mammoth Biosciences is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Mammoth Biosciences is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Mammoth Biosciences.
Mammoth Biosciences financials insights
Gather financial insights about Mammoth Biosciences, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2018
Series A
$23M
2020
Series B
$45M
Series C
$45M
2021
Series D
$150M
Mammoth Biosciences Tech Stack
A closer look at the technologies used by Mammoth Biosciences
See more technologies
Most Recent Scoops
Person-Based
Person-Based
Person-Based
Layoffs
Layoffs
Person-Based
Mammoth Biosciences News & Media
Mammoth Biosciences Announces Nomination of MB-111 as First Development Candidate and Appoints Genetic Medicines Veteran Bob D. Brown to Board of Directors
BRISBANE, Calif.--(BUSINESS WIRE)-- #CRISPR--MB-111 utilizes the ultracompact CasPhi gene editing system to permanently disrupt expression of the APOC3 gene in the liver.Mammoth Biosciences to Present Preclinical Data on In Vivo Gene Editing of Skeletal Muscle in Non-Human Primates with an Ultracompact CRISPR System at ASGCT 2025
BRISBANE, Calif.--(BUSINESS WIRE)-- #CRISPR--Oral presentation will showcase latest results with NanoCas, Mammoth Biosciences' first efficient ultracompact extrahepatic gene editor.Mammoth Biosciences Announces New Results on NanoCas – the First Efficient Ultracompact Extrahepatic Gene Editor
BRISBANE, Calif.--(BUSINESS WIRE)-- #CRISPR--NanoCas, an ultracompact nuclease, enables efficient muscle editing in NHPs using a single AAV - advancing gene editing for hard-to-target tissues.Mammoth Biosciences to Present at 43rd Annual J.P. Morgan Healthcare Conference
BRISBANE, Calif.--(BUSINESS WIRE)-- #CRISPR--Mammoth Biosciences announces presentation at the 2025 J.P. Morgan Healthcare Conference
Read more news
Top Business Services Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Mammoth Biosciences
Sign Up For FreeTo access detailed company insights
Mammoth Biosciences is a biotechnology company leveraging the diversity of life to build the next generation of CRISPR products to cure and detect disease. The company is based in Brisbane, California.... Read More
